BBVA
SRPT icon

Banco Bilbao Vizcaya Argentaria’s Sarepta Therapeutics SRPT Stock Holding History

Banco Bilbao Vizcaya Argentaria’s Portfolio SRPT Stock Details SRPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-4,500
Closed -$721K – 745
2020
Q2 		$721K Buy
4,500
+1,500
+50% +$204K 0.02% 466
2020
Q1 		$293K Hold
3,000
– – 0.01% 573
2019
Q4 		$387K Buy
+3,000
New +$303K 0.01% 572

Other funds holding SRPT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Banco Bilbao Vizcaya Argentaria's SRPT Position: Q3 2020 in Review

Banco Bilbao Vizcaya Argentaria sold out of Sarepta Therapeutics (SRPT) in Q3 2020, closing a stake of 4,500 shares — an estimated $721K sold.

Banco Bilbao Vizcaya Argentaria first reported a position in SRPT in Q4 2019 and held it in 3 quarters. The position peaked at $721K in Q2 2020. 404 funds tracked by Wall St. Rank hold SRPT as of Q3 2020.

  • Banco Bilbao Vizcaya Argentaria reported no remaining Sarepta Therapeutics position as of Q3 2020 after selling out during the quarter.
  • Banco Bilbao Vizcaya Argentaria sold 4,500 Sarepta Therapeutics shares in Q3 2020, an estimated $721K.
  • Banco Bilbao Vizcaya Argentaria first reported a position in Sarepta Therapeutics in Q4 2019 and held it in 3 quarters.
  • Banco Bilbao Vizcaya Argentaria's Sarepta Therapeutics position peaked at $721K in Q2 2020.
  • 404 funds tracked by Wall St. Rank held Sarepta Therapeutics as of Q3 2020.

Based on Banco Bilbao Vizcaya Argentaria's 13F filing for Q3 2020, filed 12 Nov 2020.